Rajesh K Rajpal et al.
Journal of cataract and refractive surgery, 39(2), 158-167 (2012-12-12)
To examine the efficacy and safety of a new gel formulation loteprednol etabonate 0.5% in the treatment of inflammation and pain after cataract surgery. Seventeen United States clinical sites. Prospective double-masked parallel-group study. Patients with anterior chamber cell (ACC) grade